147 related articles for article (PubMed ID: 26429718)
1. Synthesis and Pharmacological Effects of the Anti-Cancer Agent 2-Methoxyestradiol.
Solum EJ; Akselsen ØW; Vik A; Hansen TV
Curr Pharm Des; 2015; 21(38):5453-66. PubMed ID: 26429718
[TBL] [Abstract][Full Text] [Related]
2. Synthetic 2-methoxyestradiol derivatives: structure-activity relationships.
Peyrat JF; Brion JD; Alami M
Curr Med Chem; 2012; 19(24):4142-56. PubMed ID: 22709003
[TBL] [Abstract][Full Text] [Related]
3. The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors.
Schumacher G; Neuhaus P
J Cancer Res Clin Oncol; 2001 Jul; 127(7):405-10. PubMed ID: 11469676
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, molecular modeling and biological evaluation of potent analogs of 2-methoxyestradiol.
Al-Kazaale N; Tran PT; Haidari F; Solum EJ; Liekens S; Vervaeke P; Sylte I; Cheng JJ; Vik A; Hansen TV
Steroids; 2018 Aug; 136():47-55. PubMed ID: 29772242
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site.
Cushman M; He HM; Katzenellenbogen JA; Lin CM; Hamel E
J Med Chem; 1995 Jun; 38(12):2041-9. PubMed ID: 7783135
[TBL] [Abstract][Full Text] [Related]
6. Effects of estrogen metabolite 2-methoxyestradiol on tumor suppressor protein p53 and proliferation of breast cancer cells.
Siebert AE; Sanchez AL; Dinda S; Moudgil VK
Syst Biol Reprod Med; 2011 Dec; 57(6):279-87. PubMed ID: 22077725
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimitotic activity of novel 2-methoxyestradiol analogs.
Rao PN; Cessac JW; Tinley TL; Mooberry SL
Steroids; 2002 Dec; 67(13-14):1079-89. PubMed ID: 12441194
[TBL] [Abstract][Full Text] [Related]
8. DNA strand breaks induced by nuclear hijacking of neuronal NOS as an anti-cancer effect of 2-methoxyestradiol.
Gorska M; Kuban-Jankowska A; Zmijewski M; Marino Gammazza A; Cappello F; Wnuk M; Gorzynik M; Rzeszutek I; Daca A; Lewinska A; Wozniak M
Oncotarget; 2015 Jun; 6(17):15449-63. PubMed ID: 25972363
[TBL] [Abstract][Full Text] [Related]
9. 2-Methoxyestradiol, an endogenous 17β-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism.
Schaufelberger SA; Rosselli M; Barchiesi F; Gillespie DG; Jackson EK; Dubey RK
Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E313-22. PubMed ID: 26732685
[TBL] [Abstract][Full Text] [Related]
10. 2-Methoxyestradiol, a promising anticancer agent.
Lakhani NJ; Sarkar MA; Venitz J; Figg WD
Pharmacotherapy; 2003 Feb; 23(2):165-72. PubMed ID: 12587805
[TBL] [Abstract][Full Text] [Related]
11. 2-Methoxyestradiol and analogs as novel antiproliferative agents: analysis of three-dimensional quantitative structure-activity relationships for DNA synthesis inhibition and estrogen receptor binding.
Hughes RA; Harris T; Altmann E; McAllister D; Vlahos R; Robertson A; Cushman M; Wang Z; Stewart AG
Mol Pharmacol; 2002 May; 61(5):1053-69. PubMed ID: 11961123
[TBL] [Abstract][Full Text] [Related]
12. SAR studies of 2-methoxyestradiol and development of its analogs as probes of anti-tumor mechanisms.
Ho A; Kim YE; Lee H; Cyrus K; Baek SH; Kim KB
Bioorg Med Chem Lett; 2006 Jul; 16(13):3383-7. PubMed ID: 16650989
[TBL] [Abstract][Full Text] [Related]
13. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression.
Yue TL; Wang X; Louden CS; Gupta S; Pillarisetti K; Gu JL; Hart TK; Lysko PG; Feuerstein GZ
Mol Pharmacol; 1997 Jun; 51(6):951-62. PubMed ID: 9187261
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of 2-methoxyestradiol: new developments.
Mooberry SL
Drug Resist Updat; 2003 Dec; 6(6):355-61. PubMed ID: 14744499
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of radiation effects in vitro by the estrogen metabolite 2-methoxyestradiol.
Amorino GP; Freeman ML; Choy H
Radiat Res; 2000 Apr; 153(4):384-91. PubMed ID: 10760997
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol.
Klauber N; Parangi S; Flynn E; Hamel E; D'Amato RJ
Cancer Res; 1997 Jan; 57(1):81-6. PubMed ID: 8988045
[TBL] [Abstract][Full Text] [Related]
17. 2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric cancer.
Lin HL; Yang MH; Wu CW; Chen PM; Yang YP; Chu YR; Kao CL; Ku HH; Lo JF; Liou JP; Chi CW; Chiou SH
Int J Cancer; 2007 Dec; 121(11):2547-55. PubMed ID: 17680560
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluations of new analogs of 2-methoxyestradiol: inhibitors of tubulin and angiogenesis.
Solum EJ; Cheng JJ; Sørvik IB; Paulsen RE; Vik A; Hansen TV
Eur J Med Chem; 2014 Oct; 85():391-8. PubMed ID: 25108078
[TBL] [Abstract][Full Text] [Related]
19. Potential vascular actions of 2-methoxyestradiol.
Dubey RK; Jackson EK
Trends Endocrinol Metab; 2009 Oct; 20(8):374-9. PubMed ID: 19734053
[TBL] [Abstract][Full Text] [Related]
20. A short, economical synthesis of 2-methoxyestradiol, an anticancer agent in clinical trials.
Hou Y; Meyers CY; Akomeah M
J Org Chem; 2009 Aug; 74(16):6362-4. PubMed ID: 19610601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
